Skip to main content
. 2021 May 9;22(9):5019. doi: 10.3390/ijms22095019

Figure 2.

Figure 2

Tumor microenvironment mechanisms of intrinsic and acquired resistance to targeted therapies in 2WT RAS/BRAF colorectal cancer.